4//SEC Filing
CARTER BRUCE L A 4
Accession 0001214659-22-010296
CIK 0001576263other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:15 PM ET
Size
10.7 KB
Accession
0001214659-22-010296
Insider Transaction Report
Form 4
CARTER BRUCE L A
Director
Transactions
- Sale
Common Stock
2022-08-12$85.96/sh−4,893$420,612→ 6,021 total - Exercise/Conversion
Common Stock
2022-08-12$27.00/sh+10,000$270,000→ 16,021 total - Sale
Common Stock
2022-08-12$85.04/sh−5,107$434,287→ 10,914 total - Exercise/Conversion
Non Qualified Stock Option (right to buy)
2022-08-12−10,000→ 0 totalExercise: $27.00Exp: 2028-01-17→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $84.55 to $85.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $85.60 to $86.555. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The shares subject to the Option vested and became exercisable in 12 equal monthly installments following the date of grant.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeother
Related Parties
1- filerCIK 0001225503
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:15 PM ET
- Size
- 10.7 KB